Delivering Remarkable Patient Satisfactionˆ
94%
- Satisfaction with overall vision without glasses.^^,5
96%
- Satisfaction with reading on a smartphone or tablet.^^,8
92%
- Satisfaction with ability to see steps and curbs at night.^^,8
TECNIS Odyssey™ IOL
Precise vision. Every distance.
Any lighting.*
Not all products are available in all countries
Precise vision. Every distance.
Any lighting.*
Not all products are available in all countries
All Products
TECNIS Odyssey™
TECNIS OdysseyTM IOL
A high-quality, full visual range IOL*7
Enhanced Tolerance to Refractive Error**,1 | Optimised Dysphotopsia Profile***,2 | Remarkable Range of Vision†,3 | Best-in-Class Contrast††,4 |
Optimised Dysphotopsia Profile***,2
- Freeform diffractive profile contributes to a low incidence of bothersome visual disturbances.^,^^^,6
- 93% reported none or mild halos, glare or starbursts at one month post-op.^,^^^,6
TECNIS OdysseyTM IOL
A high-quality, full visual range IOL*7
FOOTNOTES
*DFU/Instructions for use Z311982E, current version
*DFU/Instructions for use Z311982E, current version
** Compared to TECNIS Synergy™ OptiBlue™ based on simulation in physiological eye models
***Compared to TECNIS Synergy™ OptiBlue™ based on bench testing
† Based on bench testing.
†† Based on bench testing
^ Values rounded to the nearest 1%
^^ Based on 3-month postoperative data from a multicenter, observational clinical study in the U.S.
^^^ Retrospective, multi-center, real-world clinical analysis of reported outcomes at 1 month post-operative visit, n=96. Symptoms reported without a specified severity level were classified as mild in the chart above.
REFERENCES
- 2024DOF4003 - Simulated tolerance to refractive error
- 2024DOF4005 - Laboratory measurement of intensity of extended objects for halo
- DOF2023CT4023 – Simulated Visual Acuity data.
- DOF2023CT4007, 2024DOF4033, DOF2019OTH4002, 2025DOF4003, 2025DOF4006 - Contrast (MTF) measurements
- 2024DOF4027 – User Acceptability Evaluation of Pseudophakic Patients Previously Implanted with the TECNIS Odyssey™ IOL. PATIENT REPORTED SPECTACLE INDEPENDENCE QUESTIONNAIRE (PRSIQ). 11 Jun 2024
- DOF2023CT4050 is clinical outcomes in the RWD study.
- 2024DOF4002 – TECNIS Odyssey Full Visual Range IOL
- 2024DOF4029 – User Acceptability Evaluation of Pseudophakic Patients Previously Implanted with the TECNIS Odyssey™ IOL. Low Light Vision Questionnaire Outcomes. 11 June 2024.
For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question.
©Johnson & Johnson and its affiliates 2025. All rights reserved.
2024PP17394 v3.0
